Securing Additional COVID-19 vaccines
As requested by Member States (MS), PAHO will leverage its Revolving Fund (RF) as the platform to facilitate regional access to COVID-19 vaccines to secure additional vaccines for MS during Q4, 2021. The RF will supplement current global and national efforts to access doses ongoing through the COVAX Mechanism or through bilateral arrangements. This initiative is one of the three pillars of PAHO’s Regional Plan of Action for Ensuring Sustainable Access to COVID-19 Vaccines as highlighted during the PAHO Executive Committee last month. The other two components are: 1) supporting the fulfilment of country commitment agreements with the COVAX Facility, and 2) supporting distribution of donations from multiple sources.